Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (16,912) $ (40,298)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,304 2,633
Non-cash interest expense 229  
Depreciation expense 86 105
Amortization 644 215
Change in warrant valuation 18 1,378
Change in contingent consideration valuation 1,841 27,626
Changes in operating assets and liabilities:    
Inventory 205  
Prepaid expenses and other current assets 777 184
Right-of-use asset 63 99
Accounts receivable (112)  
Accounts payable, accrued expenses and other liabilities (3,081) 1,848
Operating lease liability (67) (104)
Net cash used in operating activities (14,005) (6,314)
Cash flows from investing activities:    
Purchase of property and equipment (73)  
Purchase of short-term investments (7,495)  
Net cash used in investing activities (7,568)  
Cash flows from financing activities:    
Proceeds from equity facility, net of transaction costs   3,612
Proceeds from public offering, net of transaction costs   23,341
Proceeds from registered direct offerings, net of transaction costs 16,236  
Proceeds from warrant exercises 12,155  
Payment of contingent consideration (6,429)  
Payments of withholdings on shares withheld for income taxes (41) (95)
Net cash provided by financing activities 21,921 26,858
Net increase in cash and cash equivalents 348 20,544
Cash and cash equivalents, beginning of period 30,342 17,740
Cash and cash equivalents, end of period 30,690 38,284
Supplemental disclosure of cash flow information:    
Fair value of warrants issued in connection with public offering   8,111
Offering costs included in accounts payable and accrued expenses $ 38 $ 254